norui
The computed 12-month bankruptcy probability of norui is 2.6% (moderate). The 2024 annual accounts show equity of €17k and a net result of €-310. Equity is shrinking by ~23.1% per year across the filed fiscal years. Its solvency ranks better than 34% of 6647 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €17k |
| Net result | €-310 |
| Staff (FTE) | 1 |
| Better than sector | 34% |
Fragile profile, watch profitability in particular.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 6.1% | 20.3% | |
| Net result | €-310 | €4k | |
| Equity | €17k | €16k | |
| Gross operating margin | €83k | €24k | |
| Staff costs | €48k | €33k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €34k |
| Net profit | €-310 |
| Cash flow | €34k |
| Staff costs | €48k |
| Income taxes | €148 |
| Dividends | - |
| Total assets | €284k |
| Equity | €17k |
| Debt | €264k |
| of which ≤ 1y | €111k |
| of which > 1y | €150k |
| Working capital | €36k |
| Employees (FTE) | 1.0 |
| 2024 | |
|---|---|
| Current ratio | 1.32 |
| Quick ratio | 0.49 |
| Working capital ratio | 12.7% |
| Solvency | 6.1% |
| Debt / equity | 15.35 |
| Long-term debt ratio | 8.71 |
| Interest coverage | 15.37 |
| Gross margin | - |
| Net margin | - |
| ROA | -0.1% |
| ROE | -1.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €284k |
| Fixed assets | 21/28 | €137k |
| Tangible fixed assets | 22/27 | €106k |
| Financial fixed assets | 28 | €31k |
| Current assets | 29/58 | €147k |
| Stocks & contracts in progress | 3 | €92k |
| Amounts receivable within one year | 40/41 | €2k |
| Cash & bank | 54/58 | €52k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €284k |
| Equity | 10/15 | €17k |
| Contributions / capital | 10/11 | €100k |
| Accumulated profits (losses) | 14 | €-88k |
| Provisions & deferred taxes | 16 | €2k |
| Amounts payable | 17/49 | €264k |
| Amounts payable after one year | 17 | €150k |
| Amounts payable within one year | 42/48 | €111k |
| Trade debts payable within one year | 44 | €38k |
| Income statement | ||
| Gross operating margin | 9900 | €83k |
| Operating result | 9901 | €514 |
| Financial income | 75 | €1k |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €-354 |
| Income taxes | 67/77 | €148 |
| Net result for the period | 9904 | €-310 |
| Result to be appropriated | 9905 | €-310 |
| NACE primary | Retail trade(47742) |
| Legal form | Private limited company(610) |
| Incorporation | 02-02-2021 |
| Status | Active |
| Postal code | 1410 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25762H0640/00L000 | Wallonia | 1,191 m² | 1 · 122 m² | - |
| 21447B0309/00X012 | Brussels | 91 m² | 1 · 77 m² | 19.6 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-07-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "J\u00E9r\u00F4me Dory",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-07-22",
"filing_date": "2025-05-21",
"act_kind_objet": "Op\u00E9ration assimil\u00E9e \u00E0 la fusion par absorption de la SRL SKULLKID-"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2025-07-09",
"unanimous": true
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": {
"summary": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de d\u00E9charger l\u0027administrateur unique de la Soci\u00E9t\u00E9 Absorb\u00E9e pour l\u0027exercice de son mandat du 1er janvier 2025 jusqu\u0027au jour de l\u0027op\u00E9ration assimil\u00E9e \u00E0 la fusion par absorption.",
"articles": [
"5:121",
"12:26 \u00A71"
]
},
"restructuring": {
"parties": [
{
"kbo": "0762.824.034",
"name": "H\u0026S LAB",
"role": "acquiring",
"address": "Avenue des Sarcelles 46 \u00E0 1410 Waterloo",
"is_foreign": false,
"legal_form": "SRL",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0671.775.280",
"name": "SKULLKID",
"role": "absorbed",
"address": "Avenue des Sarcelles 46, \u00E0 1410 Waterloo",
"is_foreign": false,
"legal_form": "SRL",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"12:50",
"12:51",
"12:7"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2024-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "L\u0027int\u00E9gralit\u00E9 du patrimoine actif et passif de la soci\u00E9t\u00E9 absorb\u00E9e, sans exception ni r\u00E9serve, est transf\u00E9r\u00E9 \u00E0 la soci\u00E9t\u00E9 absorbante.",
"equity_transferred_eur": null,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0762.824.034",
"name_full": "H\u0026S LAB",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "J\u00E9r\u00F4me Dory",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e H\u0026S LAB a pris \u00E0 l\u0027unanimit\u00E9 des r\u00E9solutions pour proc\u00E9der \u00E0 une op\u00E9ration assimil\u00E9e \u00E0 la fusion par absorption de la soci\u00E9t\u00E9 SKULLKID. L\u0027int\u00E9gralit\u00E9 du patrimoine de SKULLKID est transf\u00E9r\u00E9e \u00E0 H\u0026S LAB, qui devient la soci\u00E9t\u00E9 absorbante. L\u0027op\u00E9ration est comptabilis\u00E9e r\u00E9troactivement \u00E0 partir du 1er janvier 2025.",
"co_filed_documents": [
"exp\u00E9dition conforme de l\u0027acte",
"procuration",
"statuts coordonn\u00E9s"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}03-06-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "Dimitri CLEENEWERCK de CRAYENCOUR",
"firm_city": null,
"firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-06-03",
"filing_date": "2025-05-01",
"act_kind_objet": ""
},
"decision": {
"body": null,
"act_date": "2025-05-13",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": {
"summary": "The operation is assimilated to a merger by absorption, dispensing the board of directors and the external certified auditor or expert accountant from establishing the reports.",
"articles": [
"12:7"
]
},
"restructuring": {
"parties": [
{
"kbo": "0762.824.034",
"name": "H\u0026S LAB",
"role": "acquiring",
"address": "Avenue des Sarcelles 46 - 1410 Waterloo",
"is_foreign": false,
"legal_form": "SRL",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0671.775.280",
"name": "SKULLKID",
"role": "absorbed",
"address": "Chemin des Pins, 21 - 1180 Bruxelles",
"is_foreign": false,
"legal_form": "SRL",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:50",
"12:7",
"12:57"
],
"is_cross_border": false,
"is_silent_merger": true,
"balance_basis_date": "2024-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": true,
"patrimony_description": "The entire assets and liabilities of the absorbed company, SRL SKULLKID, as of 31/12/2024, are transferred to the acquiring company, SRL H\u0026S LAB.",
"equity_transferred_eur": null,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0762.824.034",
"name_full": "H\u0026S LAB",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Benjamin Schueremans",
"org_rep_person_name": null
},
"summary_narrative": "La S.R.L. H\u0026S LAB, soci\u00E9t\u00E9 absorbante, se propose de fusionner avec la S.R.L. SKULLKID, soci\u00E9t\u00E9 absorb\u00E9e, dont elle d\u00E9tient d\u00E9j\u00E0 l\u0027ensemble des actions. Cette op\u00E9ration, assimil\u00E9e \u00E0 une fusion par absorption, vise \u00E0 rationaliser la gestion et \u00E0 renforcer l\u0027assise financi\u00E8re de H\u0026S LAB. Elle est bas\u00E9e sur les comptes annuels arr\u00EAt\u00E9s au 31/12/2024 et sera comptablement effective \u00E0 partir du 01/01/2025.",
"co_filed_documents": [],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | norui |
| Trade nameFR | NORUI |